FIELD: medicine, pharmaceutics.
SUBSTANCE: group of inventions refers to pharmaceutics. The method involves introducing a liposome-containing drug preparation. The liposome-containing drug preparation contains a dispersion of unilamellar liposomes prepared of a suspension of multilamellar liposomes of phospholipid group similar in composition with human cell membrane phospholipids. Linear size of the unilamellar liposomes are specified in view of the conformity to linear size of influenza virions.
EFFECT: method and drug preparation provide virus inhibitory action in consistently changing antigenic structure of various influenza virus strains and eliminate hepatotoxic action by immediate effect on lipid membrane of influenza virus.
17 cl, 2 dwg, 2 tbl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| YAMAL STRAIN OF AVIAN INFLUENZA VIRUS OF ALPHAINFLUENZAVIRUS GENUS OF INFLUENZA A VIRUS SUBTYPE H5N1 SPECIES FOR THE MANUFACTURE OF BIOLOGICAL PRODUCTS FOR THE SPECIFIC PREVENTION OF AVIAN INFLUENZA TYPE A SUBTYPE H5 | 2022 |
|
RU2796987C1 |
| METHOD FOR MAKING INACTIVATED EMULSIFIED AVIAN INFLUENZA VACCINE AND INACTIVATED EMULSIFIED AVIAN INFLUENZA VACCINE | 2008 |
|
RU2358760C1 |
| VIROSOMES CONTAINING HEMAGGLUTININ EXTRACTED FROM INFLUENZA VIRUS PRODUCED IN THE CELL LINES, COMPOSITIONS, CONTAINING SAID VIROSOMES, MEANS OF MANUFACTURING AND APPLICATIONS | 2008 |
|
RU2441647C2 |
| STRAIN A/CHIKEN/KOSTROMA/3175/17 H5N2 OF AVIAN INFLUENZA VIRUS SUBTYPE H5N2 INFUENZA A VIRUS OF GENUS ALPHAINFLUENZAVIRUS TO CONTROL ANTIGENIC AND IMMUNOGENIC ACTIVITY OF AVIAN INFLUENZA VACCINES AND FOR MAKING ANTIGEN-CONTAINING DIAGNOSTICUMS | 2020 |
|
RU2736788C1 |
| AVIAN INFLUENZA STRAIN A/Goose/Krasnoozerskoye/627/05 SUBTYPE H5N1 FOR STUDY OF STRENGTH OF THERAPEUTIC AND PREVENTIVE INFLUENZA AGENTS | 2008 |
|
RU2366709C1 |
| STRAIN OF AVIAN INFLUENZA A VIRUS (H5N2) GKV N 2340 FOR INFLUENZA INFECTION MODELLING | 1999 |
|
RU2163637C1 |
| DRUG FOR TREATMENT OF PATIENTS WITH VIRAL DISEASE | 1994 |
|
RU2118163C1 |
| SYNTHETIC MEMBRANE VESICLES CONTAINING FUNCTIONALLY-ACTIVE FUSED PEPTIDES AS SYSTEMS FOR ADMINISTRATION OF PHARMACEUTICAL MEANS, METHOD OF PREPARATION THEREOF, AND THEIR APPLICATION FOR PREPARING ANTI-AIDS MEANS | 1992 |
|
RU2125868C1 |
| METHOD OF PREPARING LIPOSOMAL PREPARATIONS | 1998 |
|
RU2130771C1 |
| INACTIVATED VACCINE AGAINST AVIAN INFLUENZA EMULSIFIFIED BY FLU PROTECT H5 AND METHOD OF AVIAN INFLUENZA PREVENTION | 2007 |
|
RU2350350C1 |
